Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

WU Yimei, SHENG Yuehong, LIU Yi, XIE Congjing, GE Jiyun, HUANG Yufeng. Pharmacological monitoring in a case of primary hepatocellular carcinoma with type 2 diabetes mellitus followed by hepatic abscess after radiofrequency ablation[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(4): 365-369. doi: 10.3969/j.issn.1006-0111.2019.04.016
Citation: WU Yimei, SHENG Yuehong, LIU Yi, XIE Congjing, GE Jiyun, HUANG Yufeng. Pharmacological monitoring in a case of primary hepatocellular carcinoma with type 2 diabetes mellitus followed by hepatic abscess after radiofrequency ablation[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(4): 365-369. doi: 10.3969/j.issn.1006-0111.2019.04.016

Pharmacological monitoring in a case of primary hepatocellular carcinoma with type 2 diabetes mellitus followed by hepatic abscess after radiofrequency ablation

doi: 10.3969/j.issn.1006-0111.2019.04.016
  • Received Date: 2018-05-23
  • Rev Recd Date: 2019-05-14
  • Objective To investigate the pharmacological monitoring in a hepatic abscess patient after radiofrequency ablation for primary hepatocellular carcinoma with type 2 diabetes mellitus. Methods The patient's liver and kidney function were monitored to tailor the medication regimen.The antibiotic therapy was adjusted based on the blood culture results.Blood pressure and blood sugar were also closely monitored.Pharmaceutical care is provided based on the diseases progress,the optimization of drug regimens,the monitoring of adverse drug reactions and interactions. Results In the course of treatment,no adverse drug reactions occurred.The infection was under control and the liver and kidney function returned to normal.The patient was recovered and discharged after 31 days of hospital stay. Conclusion Pharmaceutical care plays an active role in the antibiotic treatment for the seriously infected patients.
  • [1] PARK S I,LEE D Y,WON J Y,et al.Extrahepatic collateral supply of hepatocellular carcinoma by the intercostal arteries[J].J Vasc Interv Radiol,2003,14(4):461-468.
    [2] SUH S H,WON J Y,LEE D Y,et al.Chemoembolization of the left inferior phrenic artery in patients with hepatocellular carcinoma:radiographic findings and clinical outcome[J].J Vasc Interv Radiol,2005,16(12):1741-1745.
    [3] CHEN M S,LI J Q,ZHENG Y,et al.A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma[J].Ann Surg,2006,243(3):32l-328.
    [4] CHEN M H,YANG W,YAN K,et al.Large liver tumors:protocol for radiofrequency ablation and its clinical application in 110 patients:mathematic model,overlapping mode,and electrode placement process[J].Radiology,2004,232(1):260-271.
    [5] 高文,陈敏华,严昆,等.射频消融治疗非手术适应证小肝癌疗效分析[J].中国医学影像技术,2007,23(2):254-257.
    [6] 徐瑞琴,冯喜英,汪海燕,等.患者应用头孢类药物不良反应与其过敏史相关性的调查[J].临床医学,2009,29(4):119-120.
    [7] 周远华,方海顺,苏广海,等.注射用脂溶性维生素(I)与两种常用输液的配伍稳定性考察[J].中国药房,2013,16(4):573-576.
    [8] MELONI M F,GOLDBERG S N,MOSER V,et al.Colonic perforation and abscess following radiofrequency ablation treatment of hepatoma[J].Eur J Ultrasound,2002,15(1-2):73-76.
    [9] SHIBATA T,YAMAMOTO Y,YAMAMOTO N,et al.Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors:incidence and risk factors[J].J Vasc Interv Radiol,2003,14(12):1535-1542.
    [10] 姚健楠,刘福全,岳振东,等.射频消融治疗原发性肝癌围手术期安全性分析[J].中国肿瘤临床,2012(7):404-407.
    [11] 晏建军,严以群,周飞国,等.糖尿病合并肝脓肿的外科诊治[J].肝胆外科杂志,2002,10(2):96-97.
    [12] 王健,闫子光,佟小强,等.肝肿瘤射频消融术后感染性并发症的处理[J].中国介入影像与治疗学,2016,13(3):155-158.
    [13] 宗登伟,郭晨阳,黎海亮,等.肝肿瘤CT引导经皮射频消融重要并发症临床分析[J].当代医学,2013(27):8-10.
    [14] 侯继野,姜杨,董延龙,等.肝脏肿瘤患者射频消融术后感染相关并发症及其临床分析[J].中华医院感染学杂志,2016,26(22):5163-5165.
    [15] SHI S,XIA W,GUO H,et al.Unique characteristics of pyogenic liver abscesses of biliary origin[J].Surgery,2016:S0039606015009514.
    [16] 高文,陈敏华,严昆,等.射频消融治疗非手术适应证小肝癌疗效分析[J].中国医学影像技术,2007,23(2):254-257.
    [17] 张列祥,郑晶,陆海,等.天晴甘美治疗重型颅脑损伤后肝功能损害的临床研究[J].重庆医学,2015(28).
    [18] 程时,丁海勤.谷胱甘肽及其抗氧化作用今日谈[J].生理科学进展,2002,33(1):85-90.
    [19] 王能,钱国军,沈强,等.经皮肝穿刺射频治疗肝恶性肿瘤的严重并发症分析[J].中华肝胆外科杂志,2011,17(3):186-188.
    [20] 白浪,徐珊玲,王晓辉,等.Ⅱ型糖尿病合并肝脓肿32例临床分析[J].寄生虫病与感染性疾病,2005,3(3):116-117.
    [21] 张燕荣,甄健存,等.依据《药品不良反应信息通报》探讨避免药品不良反应发生的措施[J].中国医院药学杂志,2015,35(2):156-160.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(2904) PDF downloads(590) Cited by()

Related
Proportional views

Pharmacological monitoring in a case of primary hepatocellular carcinoma with type 2 diabetes mellitus followed by hepatic abscess after radiofrequency ablation

doi: 10.3969/j.issn.1006-0111.2019.04.016

Abstract: Objective To investigate the pharmacological monitoring in a hepatic abscess patient after radiofrequency ablation for primary hepatocellular carcinoma with type 2 diabetes mellitus. Methods The patient's liver and kidney function were monitored to tailor the medication regimen.The antibiotic therapy was adjusted based on the blood culture results.Blood pressure and blood sugar were also closely monitored.Pharmaceutical care is provided based on the diseases progress,the optimization of drug regimens,the monitoring of adverse drug reactions and interactions. Results In the course of treatment,no adverse drug reactions occurred.The infection was under control and the liver and kidney function returned to normal.The patient was recovered and discharged after 31 days of hospital stay. Conclusion Pharmaceutical care plays an active role in the antibiotic treatment for the seriously infected patients.

WU Yimei, SHENG Yuehong, LIU Yi, XIE Congjing, GE Jiyun, HUANG Yufeng. Pharmacological monitoring in a case of primary hepatocellular carcinoma with type 2 diabetes mellitus followed by hepatic abscess after radiofrequency ablation[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(4): 365-369. doi: 10.3969/j.issn.1006-0111.2019.04.016
Citation: WU Yimei, SHENG Yuehong, LIU Yi, XIE Congjing, GE Jiyun, HUANG Yufeng. Pharmacological monitoring in a case of primary hepatocellular carcinoma with type 2 diabetes mellitus followed by hepatic abscess after radiofrequency ablation[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(4): 365-369. doi: 10.3969/j.issn.1006-0111.2019.04.016
Reference (21)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return